EI
TTPH

EAM Investors’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

EAM Investors’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-4,716
Closed -$4.47M – 374
2015
Q2 		$4.47M Sell
4,716
-1,510
-24% -$1.23M 0.52% 46
2015
Q1 		$4.56M Sell
6,226
-2,286
-27% -$1.72M 0.53% 31
2014
Q4 		$6.76M Buy
8,512
+882
+12% +$475K 0.94% 4
2014
Q3 		$3.04M Buy
+7,630
New +$2.04M 0.62% 18
2014
Q1 		– Sell
-6,375
Closed -$1.72M – 377
2013
Q4 		$1.72M Sell
6,375
-41
-0.6% -$9.78K 0.31% 118
2013
Q3 		$1.46M Buy
+6,416
New +$1.12M 0.29% 129

Other funds holding TTPH

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

EAM Investors's TTPH Position: Q3 2015 in Review

EAM Investors sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q3 2015, closing a stake of 4,716 shares — an estimated $4.47M sold.

EAM Investors first reported a position in TTPH in Q3 2013 and held it in 6 quarters. The position peaked at $6.76M in Q4 2014. 105 funds tracked by Wall St. Rank hold TTPH as of Q3 2015.

  • EAM Investors reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q3 2015 after selling out during the quarter.
  • EAM Investors sold 4,716 Tetraphase Pharmaceuticals, Inc. shares in Q3 2015, an estimated $4.47M.
  • EAM Investors first reported a position in Tetraphase Pharmaceuticals, Inc. in Q3 2013 and held it in 6 quarters.
  • EAM Investors's Tetraphase Pharmaceuticals, Inc. position peaked at $6.76M in Q4 2014.
  • 105 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q3 2015.

Based on EAM Investors's 13F filing for Q3 2015, filed 6 Nov 2015.